Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex

Berton, 2006, Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress, Science, 311, 864, 10.1126/science.1120972 Conti, 2002, cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs, J. Neurosci., 22, 3262, 10.1523/JNEUROSCI.22-08-03262.2002 Covington, 2009, Antidepressant actions of histone deacetylase inhibitors, J. Neurosci., 29, 11451, 10.1523/JNEUROSCI.1758-09.2009 Cryan, 2002, Assessing antidepressant activity in rodents: recent developments and future needs, Trends Pharmacol. Sci., 23, 238, 10.1016/S0165-6147(02)02017-5 Drevets, 2000, Neuroimaging studies of mood disorders, Biol. Psychiatry, 48, 813, 10.1016/S0006-3223(00)01020-9 Drevets, 2007, Orbitofrontal cortex function and structure in depression, Ann. N. Y. Acad. Sci., 1121, 499, 10.1196/annals.1401.029 Dwivedi, 2003, Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects, Arch. Gen. Psychiatry, 60, 804, 10.1001/archpsyc.60.8.804 Eisch, 2003, Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression, Biol. Psychiatry, 54, 994, 10.1016/j.biopsych.2003.08.003 Hobara, 2010, Altered gene expression of histone deacetylases in mood disorder patients, J. Psychiatr. Res., 44, 263, 10.1016/j.jpsychires.2009.08.015 Karege, 2005, Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs, Mol. Brain Res., 136, 29, 10.1016/j.molbrainres.2004.12.020 Krishnan, 2008, The molecular neurobiology of depression, Nature, 455, 894, 10.1038/nature07455 Paxinos, 1980, Ache-stained horizontal sections of the rat-brain in stereotaxic coordinates, J. Neurosci. Methods, 3, 129, 10.1016/0165-0270(80)90021-7 Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0 Renard, 2003, Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test, Fundam. Clin. Pharmacol., 17, 449, 10.1046/j.1472-8206.2003.00160.x Rolls, 2004, The functions of the orbitofrontal cortex, Brain Cogn., 55, 11, 10.1016/S0278-2626(03)00277-X Rupniak, 2003, Animal models of depression: challenges from a drug development perspective, Behav. Pharmacol., 14, 385 Schroeder, 2007, Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse, Biol. Psychiatry, 62, 55, 10.1016/j.biopsych.2006.06.036 Shirayama, 2002, Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression, J. Neurosci., 22, 3251, 10.1523/JNEUROSCI.22-08-03251.2002 Simonini, 2006, The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases, Proc. Natl. Acad. Sci. U. S. A., 103, 1587, 10.1073/pnas.0510341103 Steru, 1985, The tail suspension test—a new method for screening antidepressants in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Tsankova, 2006, Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action, Nat. Neurosci., 9, 519, 10.1038/nn1659 Xing, 2011, Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test, Brain Res. Bull., 85, 153, 10.1016/j.brainresbull.2011.03.007 Yamada, 2003, Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder, J. Neural Transm., 110, 671, 10.1007/s00702-002-0810-8